In the biopharma world, every market-shaking drug or paradigm-shifting company starts in the lab. Endpoints Catalysts will ask: Which wonky ideas and early experiments have the potential to steer the next big moves for companies and investors? Join us for the first iteration of a new signature event that will scrutinize the basic science that excites experts today, and predict how it might become the breakthroughs that shape the industry in the future.